Peptide-based drug discovery: Current status and recent advances

Area of Science:

• Peptide chemistry and drug discovery.

Background:

• Peptide therapeutics have evolved significantly from laboratory synthesis to clinical applications.
• Advances in peptide chemistry, including microwave irradiation and ligation chemistry, have accelerated development.
• Emerging technologies like DNA-encoded libraries (DELs) and display techniques are transforming peptide drug discovery.

Purpose of the Study:

• To review the current landscape of peptide therapeutics.
• To analyze US Food and Drug Administration (FDA)-approved peptide drugs and those in clinical trials.
• To highlight recent advancements in peptide-based drug discovery.

Main Methods:

• Analysis of FDA-approved peptide drugs.
• Review of peptide drugs currently in clinical trials.
• Examination of evolving peptide synthesis and discovery technologies.

Main Results:

• Peptide therapeutics are increasingly successful, with numerous drugs approved and in development.
• Innovative chemical synthesis techniques and novel discovery platforms are key drivers of progress.
• The field is dynamic, with ongoing research expanding the potential of peptide drugs.

Conclusions:

• Peptide drug discovery is a rapidly advancing field with significant therapeutic potential.
• Technological innovations are crucial for the continued development and success of peptide therapeutics.
• The analysis provides insights into the current state and future directions of peptide-based medicines.